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Dietary polyphenols have been widely investigated as antidiabetic agents in cell, ani-
mals, human study, and clinical trial. The number of publication (Indexed by Web of
Science) on “polyphenols and diabetes” significantly increased since 2010. This review
highlights the advances andopportunities of dietary polyphenols as antidiabetic agents.
Dietary polyphenols prevent and manage Type 2 diabetes mellitus via the insulin-
dependent approaches, for instance, protection of pancreatic islet 𝛽-cell, reduction of
𝛽-cell apoptosis, promotion of 𝛽-cell proliferation, attenuation of oxidative stress, acti-
vation of insulin signaling, and stimulation of pancreas to secrete insulin, as well as the
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insulin-independent approaches including inhibition of glucose absorption, inhibition
of digestive enzymes, regulation of intestinal microbiota, modification of inflammation
response, and inhibition of the formation of advanced glycation end products. More-
over, dietary polyphenols ameliorate diabetic complications, such as vascular dysfunc-
tion, nephropathy, retinopathy, neuropathy, cardiomyopathy, coronary diseases, renal
failure, and so on. The structure–activity relationship of polyphenols as antidiabetic
agents is still not clear. The individual flavonoid or isoflavone has no therapeutic effect
on diabetic patients, although the clinical data are very limited. Resveratrol, curcumin,
and anthocyanins showed antidiabetic activity in human study. How hyperglycemia
influences the bioavailability and bioactivity of dietary polyphenols is not well under-
stood. An understanding of how diabetes alters the bioavailability and bioactivity of
dietary polyphenols will lead to an improvement in their benefits and clinical outcomes.
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1 NATURAL PRODUCTS BASED
ANTIDIABETIC DRUG DISCOVERY
Historically, natural products have been playing an important role in
human health. Plants have been traditionally used to combat diseases
in the medical traditions of different societies. Therefore, not surpris-
inglymanymoderndrugs represent plant-derived substances for treat-
ing Type 2 diabetes (T2D) mellitus, with multiple prominent examples,
such as acarbose, andrographolide, and galegine, which contributed to
the discovery of biguanides (Figure 1).
With so many successful records, the advantages of natural
products-based drug discovery highlight biodiversity of resources,
structural and chemical diversity, drug-likeness and biological friend-
liness, biocompatibility and biological validation, hints on efficacy
and safety from application of traditional medicines, opportunities
for use as scaffolds for chemical modifications to optimize potency,
multi-targeted mechanism of action for diseases of complex eti-
ology, and available to large-scale production by biotechnological
approaches.
Biodiversity of resources of natural products from rich ecosys-
tems includes plants, fungi, bacteria, algae, animals, minerals, and
their metabolites, which provide a unique and renewable resource
for the discovering of potential new polyphenols with novel bioactivi-
ties (Hoffmann et al., 2018). One key advantage of natural products is
their enormous structural diversity; they typically have higher molec-
ular weights, more sp3 carbon atoms, and less nitrogen and halogen
elements; a greater number of chiral centers increased steric com-
plexity and greater molecular rigidity than either synthetic drugs or
combinatorial libraries (Li & Vederas, 2009). The significance of nat-
ural products chemistry is the introduction of novel molecular skele-
tons and functionalities, which may change their bioavailability and
bio-efficacy. Moreover, natural polyphenols produced by living organ-
isms are evolutionarily optimized as drug-likeness and biological
friendliness than totally synthetic chemicals. Applicationof biotechnol-
ogy including transgenic plants, microbial fermentation, and enzyme
engineering enables the large-scale production of specific natural
bioactive polyphenols (Atanasov et al., 2015; Cao, Chen, Jassbi, & Xiao,
2015; Xiao, Muzashvili, & Georgiev, 2014).
The medicinal herbs usually contain multiple bioactive compounds
including with multiple targets diabetic therapy. In traditional Chi-
nese medicine, purslane, Fenugreek seeds, and mulberry leaves were
widely applied to treat diabetes (Figure 2). Fenugreek seeds con-
tained soluble dietary fibers (galactomannan), diosgenin, trigonelline,
flavone C-glycosides, and other ingredients that showed hypoglycemic
activity. Galactomannan can delay gastric emptying of carbohydrates,
inhibit digestive enzymes, and regulate intestinal flora (Zentek et al.,
2013). Diosgenin protects pancreatic islet 𝛽-cells and upregulates hep-
atic glucose kinase (Fuller & Stephen, 2015). Trigonelline improves
insulin signaling pathway (Aldakinah, Al-Shorbagy, Abdallah, & El-
Abhar, 2017), attenuates the endoplasmic reticulum stress and oxida-
tive stress in type 2 diabetic rats (Mayakrishnan et al., 2015), and
affects the regeneration of pancreatic islet 𝛽-cells, the secretion
of insulin, and glucose metabolizing enzymes (Zhou, Chan, & Zhou,
2012). Flavone C-glycosides can inhibit digestive enzymes, activate
insulin signaling, and reduce the formation of advanced glycation end
products (Xiao, Capanoglu, Jassbi, & Miron, 2016). Dietary polyphe-
nols have been widely investigated as antidiabetic agents in cell,
animals, human study, and clinical trial. The number of publication
(Indexed by Web of Science) on “polyphenols and diabetes” signifi-
cantly increased since 2010 (Figure 3). This review will focus on the
advances and opportunities of dietary polyphenols as antidiabetic
agents.
20 SUN ET AL.
F IGURE 1 Natural antidiabetic drugs
F IGURE 2 Purslane, fenugreek seeds, andmulberry leaves were applied to treat diabetes in Traditional ChineseMedicine
F IGURE 3 Increasing publications on “polyphenols and diabetes” since 2010 (Indexed byWeb of Science)
2 DIETARY POLYPHENOLS
Phenolics are the intricate category of bioactive molecules produced
by shikimate and acetate pathways that occur naturally. Almost all
medicinal and edible plants contain phenolic compounds. Among the
richest dietary sources of phenolic and polyphenolic compounds are
fruits, spices, seeds, and vegetables. Moreover, certain beverages like
tea, coffee, and wine contribute significantly to the daily intake of
phenolics (Pérez-Jiménez, Neveu, Vos, & Scalbert, 2010). Due to their
structural diversity and possessing therapeutic activities, researchers
have focused on phenolic compounds exploring their use as medic-
inal agents. Compounds with one phenolic ring are generally classi-
fied as simple phenols, whereas those with more than one phenolic
ring referred to as polyphenols (Figure 4). There are four major groups
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F IGURE 4 Chemical structures of natural polyphenols
of phenolic compounds: simple phenols (designated as phenolic acid),
lignans, stilbenes, and polyphenols (referred to as flavonoids). Among
polyphenols, flavonoids represent thewide-rangingmetabolites,which
include flavonols, flavones, flavanones, isoflavones, and anthocyanins
(Figure 3).
Phenolic acids are the aromatic carboxylic acid with hydroxyl
derivatives that haveonlyonephenolic ring in their structure andareof
two types, for example, hydroxybenzoic acid and hydroxycinnamic acid
derivatives (Kondratyuk & Pezzuto, 2004). Caffeic, p-coumaric, ferulic,
and sinapic acids are the hydroxycinnamic acid derivatives that are
more abundant in plant as compared to benzoic acid derivatives such
as gallic acid, protocatechuic acid, and p-hydroxybenzoic acid.
With 1,2-diphenylethylene nucleus, stilbenes consist of two pheno-
lic rings connected by a methylene bridge (Rivière, Pawlus, &Mérillon,
2012). Stilbenes are not found abundantly in plants, and thus our
diet always deficit with it. Resveratrol (3,4′,5-trihydroxy stilbene),
a well-known stilbenes class of polyphenol, found mainly in grapes
skin, mulberries, peanuts, and red wine (Burns, Yokota, Ashihara,
Lean, & Crozier, 2002). Anthocyanidins are present in red wine,
cereals, and certain vegetables (e.g., beans, cabbage, and onions), but
the primary source of these polyphenols is red fruits (Lee, Durst, &
Wrolstad, 2005). Cyanidine, delphinidine, malvidin, petunidine,
pelargonidine, and peonidine are the common anthocyanidin agly-
cones in the human diet (Kähkönen &Heinonen, 2003).
The most common group of polyphenols in the human diet are
flavonoids. It contains twophenolic rings,which are connectedby three
carbon atoms of an oxygen-containing heterocyclic ring. Flavonols,
flavones, flavanones, isoflavones, flavan-3-ols, and anthocyanidins are
the different types of flavonoids found in the plant-based human diet.
Flavonoids with 3-hydroxy pyran-4-one group on the C-ring known
as flavonols are prevalent in human diet, especially in tea, fruits, and
vegetables (Xiao, 2017). The dietary flavonoids in nature almost all
exist as their glycosides, such as glucoside, galactoside, rhamnoside,
arabinoside, and rutinoside. The most abundant flavonoid glycosides
in plants are flavone O/C-glycosides and flavonol O-glycosides. The
flavonoid O-glycosides are found mainly as their 3- or 7-O-glycosides
(Xiao, 2017); however, most flavonoid C-glycosides are in 6- and 8-C-
glycosidic forms (Xiao et al., 2016).
Caffeoylquinic acids are members of a larger family of chloro-
genic acids. The subfamily of caffeoylquinic acids includes several
isomers of which the most famous are 3-O-caffeoylquinic acid,
crypto-chlorogenic acid, chlorogenic acid, 1,5-di-O-caffeoylquinic acid,
3,4-di-O-caffeoylquinic acid, 3,5-di-O-caffeoylquinic acid, and 4,5-di-
O-caffeoylquinic acid. Plants use caffeoylquinic acids as precursors to
sustain the lignin biosynthesis, to defend plants from the attack of
pathogens (bacteria and fungi), or as protecting agents against dam-
ages induced by oxidative stress and UV rays (Clifford, Jaganath, Lud-
wig, & Crozier, 2017). Depending on the plant species, the amount of
caffeoylquinic acids produced changes, varying from micrograms to
grams per kilogram of dry weight. Due to their chemical structure,
caffeoylquinic acids show a good solubility in water and can easily be
extracted from natural sources (Clifford, 2000;Meinhart et al., 2017).
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Proanthocyanidins are a class of polyphenols found in a variety of
plants. Chemically, they are oligomeric flavonoids. Many are oligomers
of catechin and epicatechin and their gallic acid esters. More complex
polyphenols, having the same polymeric building block, form the group
of tannins. Anthocyanidins are a class of water-soluble pigments that
are widely found in plant tissues such as flowers, leaves, fruits, and
stems. Structurally, anthocyanidins are phenolic compounds belonging
to the flavonoids, usually in the form of glycosides, composed of agly-
cones and glycosyl groups. More than 600 anthocyanidins have been
reported, of which six anthocyanins (aglycones) including cyanidin,
malvidin, delphinidin, petunidin, peonidin, and pelargonidin accounted
for 95% of them. Anthocyanidins differ in the number and position of
hydroxyl groups on the ring, the degree of methylation of the hydroxyl
groups, and the number and location of glycosyl ligands.
3 EVIDENCE FROM THE
EPIDEMIOLOGICAL INVESTIGATION
Significant evidence from epidemiological investigations has shown
that dietary polyphenolsmight control andprevent T2Dwhile contrary
opinions also exist. A high intake of total polyphenols, total flavonoids
(specifically flavanones and dihydroflavonols), and stilbenoids is asso-
ciated with a reduced risk of diabetes in elderly persons at high risk of
cardiovascular disease in the Prevencion con Dieta Mediterranea trial
(Tresserra-Rimbau et al., 2016). Dietary flavonoids were regarded as a
related factor of reduced risk of T2D (Liu, Li, Zhang, Sun, & Xia, 2014),
for example, van Dam, Naidoo, and Landberg (2013) highlighted that
anthocyanidins and flavan-3-ols could reduce the risk of T2D and a
20-year investigation conducted in the United States received similar
effects through higher consumption of anthocyanins or anthocyanin-
rich food. Intake of dietary flavones has benefits in prevalence of
T2D in Korean women aged ≥30 years (Oh et al., 2017). Further-
more, a study involving 4,186 Korean individuals even illustrated that
the consumption of flavones and flavonols was inversely associated
with insulin resistance among male subjects (Wedick et al., 2015).
Quercetin intake was inversely related to the prevalence of T2D in
the Chinese population investigated by a validated 100-item food fre-
quency questionnaire (Yao et al., 2019). However, this study is not
convinced because the effects of co-existed other flavonoids are not
considered. Flavonoid intake from fruit and vegetables during adoles-
cence is linked with a favorable risk factor profile for T2D in early
adulthood (Penczynski et al., 2019). Contradictory results, however,
indicated that uptakeof flavonoidsmight not link to a lower risk of T2D.
A prospective cross-sectional study conducted on 38,018 women sug-
gested that there was no relationship between flavonols or flavones
consumption and the risk of T2D (Song, Manson, Buring, Sesso, &
Liu, 2005). In addition, the intake of anthocyanidins was not linked
with the risk of diabetes in women in Iowa (Nettleton et al., 2006). In
summary, the results from different epidemiological studies are incon-
sistent, whichmay be due to the large variation between different pop-
ulations andmeasurement errors in dietary intake (Talaei &Pan, 2015).
4 MECHANISMS OF DIETARY
POLYPHENOLS AS ANTIDIABETIC AGENTS
Accumulated evidences from in vivo and in vitro investigations sug-
gest a significant function of dietary polyphenols in the prevention and
management of T2D through the insulin dependent approaches, for
instance, protection of pancreatic islet 𝛽-cell, reduction of 𝛽-cell apop-
tosis, promotion of 𝛽-cell proliferation, attenuation of oxidative stress,
activation of insulin signaling, and stimulation of pancreas to secrete
insulin, as well as the insulin independent approaches including inhi-
bition of glucose absorption, inhibition of digestive enzymes, regula-
tion of intestinal microbiota, modification of inflammation response,
and inhibition of the formation of advanced glycation end products
(Table 1). Moreover, dietary polyphenols ameliorates diabetic compli-
cations, such as vascular dysfunction, nephropathy, retinopathy, neu-
ropathy, cardiomyopathy, coronary diseases, renal failure, and so on
(Figure 5).
4.1 Flavonoids
Flavonoids and extracts rich in flavonoids from coffee, guava tea,
whortleberry, olive oil, propolis, chocolate, and cocoa have beenwidely
studied as possible antidiabetic agents. Quercetin was themost widely
investigated flavonoid in the literatures for the in vivo and cellular anti-
diabetic effects in animal and cell models (Shi et al., 2019), followed
by kaempferol (Alkhalidy et al., 2018), luteolin (Sangeetha, 2019),
myricetin (Li et al., 2017), and naringenin (DenHartogh&Tsiani, 2019).
Compared with these aglycones, flavonoid O-glycosides shown less
antidiabetic potential (Xiao, 2017). However, flavonoid C-glycosides,
such as vitexin, isovitexin, swertisin, apigenin 6-C-𝛽-fucopyranoside,
and apigenin 6-C-(2″-O-𝛼-rhamnopyranosyl)-𝛽-fucopyranoside, exhib-
ited positive antidiabetic activity in hyperglycemic animals (Xiao et al.,
2016).
Dietary flavonoids showed significant hypoglycemic effect via reg-
ulation of glucose absorption (Loureiro & Martel, 2019), inhibition of
digestive enzymes (Xiao, Ni, Kai, & Chen, 2013; Xiao, Kai, Yamamoto, &
Chen, 2013), regulation of intestinal microbiota (Gowd, Karim, Shishir,
Xie, & Chen, 2019), inhibition of advanced glycation end products
formation (Xie a& Chen, 2013), and so on. Flavonoids improve the
pathogenesis of diabetes and its complications through the regulation
of glucose metabolism, hepatic enzymes activities, and a lipid profile
(Al-Ishaq, Abotaleb, Kubatka, Kajo, & Büsselberg, 2019; Zhao et al.,
2019). The hydroxyl groups attached to ring B and ring C and an unsat-
urated 2,3-bond in conjugation with a 4-carbonyl group of flavonoids
are in favor of the inhibition of digestive enzymes and advanced gly-
cation end products formation, whereas methyl and glycosidic moi-
eties make against the inhibition (Xiao, Ni, et al., 2013; Xiao, Kai, et al.,
2013; Xie & Chen, 2013). However, the structure–activity relationship
of hypoglycemic effects of dietary flavonoids in animals was not clear.
The antidiabetic activity of flavonoidC-glycosides in human and clinical
study has been rarely reported.
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TABLE 1 Antidiabetic effects of dietary phenolic compounds
Phenolic compounds Foods Promoting effect Inhibiting effect Refs.










Xiao, Ni, Kai, & Chen, 2013;
Xiao, Kai, Yamamoto, &
Chen 2013; Gowd et al.,
2019; Xie & Chen, 2013







glucose uptake in small
intestine; the process of





Jin et al., 2018; Liu et al.,
2018; Chen et al., 2018;
Chen et al., 2018
Catechins Tea leaves and redwine Insulin sensitivity; AMPK
activation; fecal excretion
of bile acids and
cholesterol







Thielecke & Boschmann ,
2009; Park et al., 2014; Xu
et al., 2019; Kobayashi
et al., 2000; Li et al., 2018;
Matsui et al., 2007;
Shimizu et al., 2000;
Solinas & Becattini, 2016;



















Kasetti et al., 2012; Jung
et al., 2007; Son et al.,
2011; Pei et al., 2016
Caffeoylquinic acids Potatoes, eggplants,
peaches, prunes, and
coffee beans




Narita & Inouye, 2009; Nurul
Islam et al., 2013; Arion
et al., 1997; Hemmerle
et al., 1997; Henry-Vitrac
















Zhu et al., 2012; Crozeir,
Jaganath & Clifford, 2009;
Roy et al., 2008; Tsuda
et al., 1999; Shi et al., 2017










Bahmanzadeh et al., 2019;
Rašković et al., 2019; Sadi
et al., 2015; Yan et al.,
2018; Zhao et al., 2019;
Bhakkiyalakshmi et al.,
2014; El-Sayed et al., 2015
Procyanidins Berries, red cabbage, apple,
cocoa, cinnamon, wine,
and nuts






Ogura et al., 2016; Yamashita
et al., 2016; Aragones
et al., 2016;
Vazquez-Flores et al., 2018
Tannins Coffee, tea, wine, grapes,
berries, apples, apricots,
barley, peaches, dry
fruits, mint, basil, and
rosemary
AMPK phosphorylation;





and enzymatic activity of
maltase, lactase and
sucrose
Hosoyama et al., 2003;
Matsui et al., 2007;




Protecting pancreatic 𝛽-cells Insulin resistance; diabetic
cardiomyopathy; oxidative
stress
Jin et al., 2018; Pivari et al.,
2019; Rashid et al., 2017;
Zha et al., 2018
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F IGURE 5 Antidiabetic mechanisms of dietary polyphenols
4.2 Isoflavones
Significant evidence from epidemiological investigations has shown
that soybean isoflavones intake is linked to a lower risk of diabetes
(Konishi et al., 2019). Soy isoflavones perform hypoglycemic effects
in Goto–Kakizaki diabetic rats via suppression of carbohydrate diges-
tion and glucose uptake in small intestine (Jin et al., 2018) and delay
the process of renal interstitial fibrosis in diabetic nephropathic rats
(Liu et al., 2018). Among soy isoflavones, puerarin, the 8-C-glucoside
of daidzein, showed best hypoglycemic effects via improving insulin
resistance and sensitivity, protecting pancreatic 𝛽-cells, exerting anti-
inflammation activity, decreasing oxidative stress, and inhibiting Mail-
lard reaction and advanced glycation end products formation (Chen
et al., 2018; Chen, Yu, & Shi, 2018). Moreover, puerarin ameliorates
diabetic complications, such as cardiovascular complications, diabetic
nephropathy, retinopathy, neuropathy, and so on. Genistein benefits
type 2 diabetes via remarkably ameliorating hyperglycemia (Fu et al.,
2012; Rockwoodet al., 2019), enhancing 𝛽-cell proliferation and reduc-
ing apoptosis (Gilbert & Liu, 2013), ameliorating cardiac inflammation
and oxidative stress (Gupta et al., 2015), improving fracture resistance
(Odle,Dennison,Al-Nakkash,Broderick,&Plochocki, 2017), ameliorat-
ing vascular dysfunction (Valsecchi et al., 2011), and alleviating diabetic
neuropathy, nephropathy, and retinopathy (Weng, Zhang,Wang,Ma, &
Song, 2019).
Although daidzein does not affect the blood glucose level and
glucose tolerance, but it induces an immunomodulatory effect in
non-obese diabetic mice, the prophylactic effect of daidzein on
the improvement of hyperglycemia, insulin resistance, dislipidemia,
obesity, inflammation, and other complications associated with T2D
was widely explored (Das et al., 2018; Huang, Xu, & Guo, 2019).
Daidzein improves glucose homeostasis in Type 2 diabetic mice
(Cheong et al., 2014). However, in a double-blind, randomized,
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placebo-controlled trial, the 6-month supplementation of daidzein or
genistein does not affect glycemic control and insulin sensitivity in Chi-
nese womenwith impaired glucose regulation (Ye et al., 2015).
Biochanin A showed hypoglycemic effect on streptozotocin-
diabetic rats (Harini, Ezhumalai, & Pugalendi, 2012). Biochanin A
significantly reduced insulin resistance, improved inulin sensitivity and
lipid profile, and attenuates neuropathic pain in diabetic rats (Chundi
et al., 2016). Formononetin treatment reduces insulin resistance and
attenuate hyperglycemia in T2D, which may be due to increasing
expression of SIRT1 in pancreatic tissues (Oza & Kulkarni, 2018).
Methylated isoflavones look like they exhibit better antidiabetic effect
than nonmethyl forms. However, it needs further investigation in
animals and human studies.
4.3 Catechins
Catechins are natural polyphenols present in edible and medicinal
plants, especially in tea leaves (Khan & Mukhtar, 2018). Catechins
show a very low bioavailability. After consumption of a single cup of
tea, plasma concentrations of catechins rinse quickly reaching a max-
imum after 2 hr, to then gradually decrease to reach the basal lev-
els within 8 hr. Pharmacokinetic studies demonstrated that in human
cells p-glycoprotein is responsible for both uptake and excretion of cat-
echins (Vaidyanathan & Walle, 2003); however, due to the high indi-
vidual variability existing between humans, the pharmacokinetics of
catechins may change considerably from person to person (Ullmann
et al., 2003).
There is a large agreement between researchers in sustaining that
catechins have a positive impact on human health. Evidence suggested
that the regular consumption of catechins could contribute to prevent
gain of weight or the onset of chronic disease such as T2Dormetabolic
syndrome (Thielecke&Boschmann, 2009; Park, Bae, Im, & Song, 2014).
In particular, catechins contribute to reduce glycaemia, enhance insulin
sensitivity, decrease blood lipids, and reduce white fat depots.
It has been demonstrated that Epigallocatechin gallate acts as a
reversible noncompetitive inhibitor of pancreatic 𝛼-glucosidase, show-
ing an IC50 value lower than that calculated for acarbose. This explains
why the assumption of a cup of tea before a meal is enough to
delay intestinal glucose adsorption (Xu et al., 2019; Li et al., 2018).
Interestingly, it has been observed that the inhibitory power of cat-
echins varies depending on their chemical structure. Kamiyama and
co-workers demonstrated that galloylated catechins are more effec-
tive than nongalloylated catechins in inhibiting 𝛼-glucosidase and 𝛼-
amylase (Kamiyama et al., 2010). Moreover, other tea polyphenols,
such as theaflavin-3-O-gallate, resulted to be potent inhibitors of mal-
tase (Matsui et al., 2007). Besides acting as glucosidase inhibitors, cat-
echins are able to interfere with the action mechanism of glucose
transporters present onto plasma membrane of intestinal cells. Stud-
ies conducted using rabbit intestinal brush-border membrane vesicles
showed that Epicatechin gallate and EGCGact as competitive inhibitor
of the Na+-dependent glucose transporter (SGLT1). (Kobayashi et al.,
2000; Shimizu, Kobayashi, Suzuki, Satsu, & Miyamoto, 2000). These
data were also confirmed by tests conducted on healthy volunteers. It
has been observed that administration of green tea powder or EGCG
prior assumption of a glucose solution reduced intestinal carbohy-
drate absorption (Tsuneki et al., 2004; Zhong, Furne, & Levitt, 2006).
Together, these results suggested that catechins modulated glucose
absorption by two independent mechanisms: inhibiting glucosidase
and/or interferingwith the glucose transport through the plasmamem-
brane of intestinal cells.
Another important question concerns the effect of catechins on glu-
cose uptake by peripheral tissues. A plethora of data confirmed that
in muscle cells, catechins stimulated either transcription or transloca-
tion of GLUT4 to plasma membrane through both PI3K- and AMPK-
dependent pathways (Ashida et al., 2004; Li et al., 2011; Takagaki et al.,
2019; Ueda et al., 2008; Ueda-Wakagi et al., 2018). Interestingly, in
adipocytes catechins modulate glucose uptake in a different mode,
depending from their chemical structure. In particular, nongallate-type
catechins stimulate PI3K activity and GLUT4 translocation onto the
plasma mebrane, recapitulating the results of studies conducted on
muscle cells. Conversely, gallate-type catechins, including EGCG, seem
to decrease insulin-induced glucose uptake (Ueda et al., 2010). It has
been suggested that suchan inhibitoryeffect couldbe the consequence
of the EGCG-induced AMPK activation. In accord with this hypothe-
sis, Li and co-workers showed that treatment of epididymal adipocytes
with EGCG leads to AMPK activation, which, in turn, inhibits the
expression of genes involved in de novo fatty acids synthesis, and, in
the same moment, increases the expression of genes associated with
lipolysis and lipid oxidization (Li et al., 2018).
Moreover, there is evidence that EGCG interferes also with the
bile acid metabolism. In fact, it has been demonstrated that chronic
assumption of EGCG favors fecal excretion of bile acids and choles-
terol. This finding explain why in mice fed with a high-fat western-
style diet, assumption of EGCGwith the diet decreases intestinal lipids
absorption, reduces adipose depots and contributes to normalize lipid
profile (Li et al., 2018). Catechins have important effects also on liver
cells. Kim and co-workers showed that low doses of EGCG stimulate
glycogen synthesis and glucose uptake, whereas inhibit lipogenesis in
liver cells (Kim, Tan, Xiao, Sun, & Qu, 2013). On the other hand, it has
been demonstrated that treatment of hepatocyteswith EGCG reduces
reactive oxygen species production, therebydampening JNK-activated
signaling pathway. Thus, acting as antioxidant, EGCG protects insulin
receptor and IRS proteins from phosphorylation on serine residues, a
phenomenon that contributes to theonset of insulin resistance (Solinas
&Becattini, 2016). Finally, it has been showed that treatment ofHepG2
cells with EGCG stimulates nuclear translocation of Nrf2, whichmodu-
lates the expression of antioxidant genes and reduces the expression of
PTP1B, one themost important negative regulators of activated insulin
receptor (Mi et al., 2018).
4.4 Hydroxycinnamic acids
Several important hydroxycinnamic acids, such as cinnamic acid, p-
coumaric acid, ferulic acid, caffeic acid, chlorgenic acid, and rosmarinic
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F IGURE 6 Chemical structure of important hydroxycinnamic acids
acid (Figure 6), have shown considerable hypoglycemic activity via in
vivo experiments, such as streptozotocin, alloxan, and dietary (high
fructose and fat diets) inducing T2D in animal models.
Cinnamic acid improved glucose intolerance and insulin resistance
in streptozotocin (STZ)-induced diabetic rats (Kasetti, Nabi, Swapna, &
Apparao, 2012). Ferulic acid reduced blood glucose level and increased
blood insulin level in several diabetic animalmodels (Jung, Kim,Hwang,
& Ha, 2007; Ohnishi et al., 2004). Ferulic acid also increased glucoki-
nase activity (Jung et al., 2007) and decreased glucose-6-phosphatase
and phosphoenolpyruvate carboxykinase activities in liver (Son, Rico,
Nam,&Kang, 2011). Caffeic acid has been studied extensively in exper-
imental diabetes and related complications. Caffeic acid shows hypo-
glycemic effects (Celik, Erdogan, & Tuzcu, 2009; Jung, Lee, Park, Jeon,
& Choi, 2006), improves insulin level (Cy, Mc, Kc, & Mc, 2010), and
enhances glucose intolerance (Bezerra et al., 2012) in diabetic animals.
p-Coumaric acid shows antidiabetic activity by reducing the
intestinal absorption of carbohydrate, modulating glucose metabolism
enzymes, improving 𝛽-cell function, stimulating insulin secretion,
increasing insulin sensitivity, activating AMP-activated protein kinase,
inhibiting adipogenesis and gluconeogenesis, and enhancing antioxi-
dant potential and anti-inflammation effects (Pei, Ou, Huang, & Ou,
2016). The supplementation of p-coumaric acid can prevent bone
loss (Yamaguchi, Uchiyama, & Lai, 2007), inhibit diabetes-associated
spontaneous destruction of periodontal tissue by (Bhattarai et al.,
2019), and alleviate diabetic nephropathy in diabetic animals (Zabad,
Samra, & Eissa, 2019).
Chlorogenic acid is the major phenolic components in coffee,
which evidently reduces the risk of type 2 diabetes. Chronic dietary
chlorogenic acid consumption attenuated cardiovascular, liver, and
metabolic changes (Bhandarkar, Brown, & Panchal, 2019). Chloro-
genic acid was found to attenuate diabetic complications in animals
such as retinopathy via inhibiting retinal neoangiogenesis (Mei et al.,
2018) and sensorineural auditory function (Hong, Nam, Woo, & Kang,
2017). However, chlorogenic acid could lower the fasting plasma
glucose and HbA1c levels during late diabetes in db/db mice (Jin
et al., 2015), and there is no sufficient evidence that decaffeinated
coffee-enriched chlorogenic acid can control blood glucose in ani-
mals (Faraji, 2018). Chlorogenic acid poorly inhibits carbohydrate-
digesting enzymes (Nyambe-Silavwe & Williamson, 2018) and weakly
impacted the fasting blood glucose level and blood glucose levels in
theoral glucose tolerance tests in kk-[a.sup.y]mice (Igarashi, Takahashi,
& Sato, 2017). Chlorogenic acid supplementation in a high-fat diet
does not protect against features of the metabolic syndrome in diet-
inducedobesemice (Mubarak,Hodgson,Considine,Croft,&Matthews,
2013).
Rosmarinic acid could protect pancreatic 𝛽-cell dysfunction
and glucolipotoxicity-mediated oxidative stress (Govindaraj &
Sorimuthu, 2015), ameliorate scopolamine-induced memory impair-
ment (Hasanein & Mahtaj, 2015) and diabetic neuropathy (Hasanein
&Mohammad, 2014), attenuate vascular dysfunction (Sotnikova et al.,
2013), and prevent diabetes-induced sexual disorders (Khaki, Imani, &
Golzar, 2012).
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4.5 Caffeoylquinic acids
It has been demonstrated that 5-caffeoylquinic acids inhibit both
human salivary and pancreatic 𝛼-amylase, suggesting that these com-
pounds could contribute to reduce intestinal glucose absorption after
meal in obese or diabetic subjects (Narita & Inouye, 2009; Nurul Islam
et al., 2013). Despite studies of pharmacokinetic highlighted that caf-
feoylquinic acids are poorly absorbed from digestive tracts (Lafay,
Morand, Manach, Besson, & Scalbert, 2006), numerous studies have
been addressed to assess whether caffeoylquinic acids could influ-
ence the metabolism of peripheral tissues. It has been reported that
in vitro dicaffeoylquinic acids inhibit hepatic glucose-6-phosphatase,
the enzyme that catalyzes the last reaction of gluconeogenesis, in a
competitive manner. This evidence raised the question whether caf-
feoylquinic acids could exert their hypoglycemic activity by inhibit-
ing hepatic glucose production (Arion et al., 1997; Hemmerle et al.,
1997; Henry-Vitrac, Ibarra, Roller, Mérillon, & Vitrac, 2010). However,
instant coffee, which contains large amount of 5-caffeoylquinic acid,
did not change the glucose adsorption in rats (Bassoli et al., 2015). This
result can be explained by hypothesizing that the concentration of caf-
feoylquinic acids in liver cells resulted too low to inhibit of theG-6-Pase
(Bassoli et al., 2015).
PTP1B is one the most promising targets to improve insulin sensi-
tivity, and overcome insulin resistance in peripheral tissues (liver, mus-
cle, and adipocytes) (Eleftheriou, Geronikaki, & Petrou, 2019). Inter-
estingly, recent studies demonstrated that chlorogenic acid and some
caffeoylquinic acid derivatives behave as noncompetitive inhibitor
of PTP1B: among all caffeoylquinic acids resulted the most potent
inhibitor, showing a Ki value of about 15 micromolar (Chen et al.,
2014; Zhang et al., 2018). These data suggest that caffeoylquinic
acids could be used to improve insulin sensitivity in obese or T2D
subjects. In keeping with this hypothesis, it has been reported
that treatment with chlorogenic acid enhances glucose uptake in
both insulin-sensitive and insulin-resistant adipocytes (Alonso-Castro,
Miranda-Torres, González-Chávez, & Salazar-Olivo, 2008).
Finally, studies conducted on human volunteers showed that the
long-term assumption of coffee or extracts rich in caffeoylquinic acids
reduces levels of blood glucose, increases the insulin response (Reis,
Dórea,&daCosta, 2018), attenuateshepatic insulin resistance (Lecoul-
tre et al., 2014), reduces serum lipids, and favors a reduction of body
weight (Martínez-López, Sarriá, Mateos, & Bravo-Clemente, 2019).
Together, these evidences support the hypothesis that caffeoylquinic
acids have a deep impact on energetic metabolism of humans and can
explainwhy the extracts rich in these compounds are recommended by
traditional medicine for treatment of diabetes and obesity (Spínola &
Castilho, 2017; Xie et al., 2019).
4.6 Anthocyanins/anthocyanidins
The biological activities of anthocyanidins have been extensively stud-
ied, including health promotion effects such as antioxidant, anti-
inflammatory, and blood glucose regulation (Zhu, Jia, Wang, Zhang, &
Xia, 2012).Anthocyanidins showedantidiabetic activitymainly via inhi-
bition of oxidative stress, improvement of insulin resistance, and pro-
motion of insulin secretion.
Anthocyanidins have a phenolic hydroxyl structure and are a class
of hydroxyl donors with strong free radical scavenging ability. Antho-
cyanidins could reduce blood glucose by enhancing the antioxidant
ability of bio-organisms through upregulating superoxide dismutase
(SOD), lowering serum malonic dialdehyde, and inhibiting increasing
thiobarbituric acid reactive substances (Roy, Sen, &Chakraborti, 2008;
Tsuda, Horio, & Osawa, 1999). In vitro experiments indicated that
cyanidin-3-glucoside protected cells from high glucose-induced oxida-
tive stress by activating of glutathione synthesis (Zhu et al., 2012).
Islet 𝛽 cells are very sensitive to oxidative stress due to low expres-
sion of antioxidant enzymes such as CAT, SOD, and GPx in islets
(Evans, Goldfine, Maddux, & Grodsky, 2003). Anthocyanin-rich mul-
berry extract exerted oxidative stress on islet cells against hyper-
glycemia through AMPK/ACC/mTOR pathway (Yan & Zheng, 2017).
Anthocyanidins could improve insulin resistance by regulating
blood lipid through reducing the levels of cholesterol, triglycerides,
and low-density cholesterol and increasing the level of apolipopro-
tein and high-density cholesterol (Shi, Loftus, McAinch, & Su, 2017).
Anthocyanidin-enriched bilberry extracts improved insulin resistance
in KK-Ay mice, and reduced total cholesterol and triglycerides in liver
and serum (Takikawa, Inoue, Horio, & Tsuda, 2010). Pro-inflammatory
factors suchasTNF-𝛼 and IL-6were foundassociatedwith insulin resis-
tance (Guo et al., 2012). Studies also shown that Cyanidin-3-glucoside
inhibited 3T3-L1 cell adipocytes, activated insulin pathway via FoxO1,
and inhibited TNF-𝛼-mediated insulin resistance (Guo et al., 2012).
Anthocyanins promoted insulin secretion in many ways (Rosanska
& Regulska-llow, 2011). Cyanidin-enriched purple potato extract pro-
moted insulin secretion by upregulating the expression of intracellular
Ca2+ signaling pathway and glucose transport-related gene (Glut2) in
mouse islet beta cells (INS1) (Sun, Du, Navarre, & Zhu, 2018). Antho-
cyanidins (delphinidin 3-arabinoside) in fermented berry beverages
regulated DPPIV and its substrate GLP-1, increased insulin secretion,
and upregulated mRNA expression of insulin receptor-related genes
(Johnson &Mejia, 2016). Delphinidin 3-rutinoside could induce GLP-1
release via a calcium-dependent kinase pathway (Kato, Tani, Terahara,
& Tsuda, 2015).
4.7 Stilbenoids
Dietary stilbenoids have shown antidiabetic activity in animal mod-
els and human studies. However, most data focused on resveratrol,
pterostilbene, and polydatin. Other stilbenoids are rarely reported
as antidiabetic agents. Resveratrol supplement improves metabolic
control (Rašković et al., 2019), increases DNA integrity and sperm
parameters (Bahmanzadeh, Goodarzi, Rezaei, Fathi, & Alizadeh, 2019),
enhances insulin sensitivity (Sadi et al., 2015) and cardiovascular func-
tion (Yan, Sun, & Xu, 2018), prevents cognitive deficits by attenuating
oxidative damage and inflammation (Gocmez et al., 2019), contributes
hepatoprotective effects (Pektaş et al., 2016), alleviates testicular dys-
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function (Faid, Al-Hussaini, & Kilarkaje, 2015), reduces oxidative stress
(Bagul,Deepthi, Sultana,&Banerjee, 2015) and inflammatory response
(Sadi et al., 2015), and protects pancreatic 𝛽-cell (Ku et al., 2012) in dia-
betic animals.
The antidiabetic action of resveratrol has several tissue targets:
liver, skeletal muscle, and pancreas. In the liver, resveratrol modifies
the activity of enzymes controlling glucose homeostasis. Indeed, it
restores normal activity of enzymes that are altered in diabetic individ-
uals. Thus, it reduces the activity of phosphoenolpyruvate carboxyk-
inase, lactate dehydrogenase, and glucose-6-phosphatase (Palsamy &
Subramanian, 2009) and increases the activity of hexokinase and pyru-
vate kinase. Moreover, resveratrol increases hepatic glycogen content
by activating glycogen synthase and inhibiting glycogen phosphorylase
(Palsamy & Subramanian, 2009). These changes lead to a reduction in
hepatic glucose output.
Another important target of resveratrol is skeletal muscle, themain
tissue responsible for glucose uptake in the body. In muscles, this com-
pound increases the number of glucose transporter GLUT4 (Burges
et al., 2011; Do et al., 2012), as well as their translocation to plasma
membrane of myocyte (Deng, Hsieh, Huang, Lu, & Hung, 2008; Tan
et al., 2012), via PI3K-Akt pathway (Chi et al., 2007), which leads to
enhanced intracellular glucose transport. Moreover, it increases fatty
acid oxidation, thus avoiding lipotoxicity that leads to insulin resistance
(Chen et al., 2011).
As far as pancreas is concerned, resveratrol improves antioxidant
defense in pancreatic tissue, because it enhances the activity of antiox-
idant enzymes (CAT, SOD, GPx, and glutathione-S-transferase) (Pal-
samy & Subramanian, 2010). Furthermore, this polyphenol is able to
reverse degeneration in beta cells in diabetic rats and also to pre-
vent beta cell apoptosis due to the inhibition of caspase-3. As a con-
sequence, plasma insulin level increases.
Inflammation is also closely related to the onset and development
of diabetes (Xu et al., 2003) and thus the anti-inflammatory effect of
resveratrol is involved in glucosehomeostasis improvement inducedby
this compound in diabetic subjects. In this context, it has been reported
that resveratrol decreases the expression of transcription factor NF-
𝜅B, as well as pro-inflammatory cytokines (IL-1𝛽 and IL-6) in liver
(Andrade et al., 2014).
Pterostilbene (trans-3,5-dimethoxy-4-hydroxystilbene) is a
dimethoxyl derivative of resveratrol, which increases bioavailabil-
ity because the presence of just one hydroxyl group (instead of three
as in the case of resveratrol) in its chemical structure makes it to
exhibit increased absorption and decreased phase II metabolism in
intestine and liver. Pterostilbene showed antidiabetic activity via
regulating glucose metabolism enzymes (Pari & Satheesh, 2006),
inhibiting digestive enzymes (Zhao et al., 2019), protecting pancreatic
𝛽-cell (Bhakkiyalakshmi et al., 2014), contributing hepatoprotective
activity (El-Sayed, Mansour, & Nady, 2015), enhancing antioxidant
signaling pathways (Elango, Dornadula, Paulmurugan, & Ramkumar,
2016), ameliorating insulin sensitivity (Kosuru & Singh, 2017), and
reducing oxidative stress (Kosuru & Singh, 2017; Kosuru et al., 2018).
Piceatannol was found to promote glucose uptake and reduce the
blood glucose levels in db/db mice (Minakawa, Miura, & Yagasaki,
2012; Uchida-Maruki et al., 2015). Polydatin ameliorates diabetic
fibronectin (Xie et al., 2012) and cardiomyopathy (Zhang et al., 2017),
improves glucose and lipid metabolism (Hao et al., 2014), and protects
diabetic heart against ischemia-reperfusion injury (Yu et al., 2018). The
structure–antidiabetic activity relationship of stilbenoids is not clear
due to limited data.
The antidiabetic action of pterostilbene is due in part to the effects
onenzymes involved inglucoseandglycogenmetabolism.This phenolic
compound decreased the expression of hepatic glucose 6-phosphatase
and fructose 1,6-biphosphatase, two gluconeogenic enzymes, and
increased the expression of the glycolytic enzyme hexokinase in rats
showing type 2 diabetes induced by streptozotocin and nicotinamide
administration (Pari & Satheesh, 2006; Satheesh & Pari, 2006). In line
with these results, Gómez-Zorita et al. (2015) showed that pteros-
tilbene decreased insulin resistance index and decreased the activity
of glucokinase in skeletal muscle from rats showing insulin resistance
induced by high-fat high-fructose feeding. In addition, in this study rats
treated with pterostilbene showed increased ratio phosphorylated-
Akt/total Akt in skeletal muscle, indicating that GLUT4 could be more
efficiently translocated to the surfacemembrane, and also increases in
parameters related to fatty acid oxidation, showing thus a protection
against lipotoxicity. Upregulation of GLUT4 by AMPK phosphorylation
in skeletal muscle has also been observed in a clinical trial carried out
in a cohort of diabetic subjects (Goh et al., 2014).
Another proposed mechanism for the antidiabetic effect of pteros-
tilbene is it antioxidant activity. In fact, several studies have shown
decreases in CAT, SOD, and GPx (Sun et al., 2019). Moreover,
Bhakkiyalakshmi et al. (2014) showed a clear reduction in oxida-
tive stress via the NF-E2-related factor 2 (Nrf2) downstream target
genes, heme oxygenas-1, CAT, SOD, and GPx, and increased expres-
sion of anti-apoptotic protein, Bcl-2 as well as the downregulated
of the pro-apoptotic proteins Bax and caspase-3, in pancreatic INS-
1E cells. With regard to the inflammation, pterostilbene has shown
interesting anti-inflammatory effects by inducing reductions in plasma
pro-inflammatory cytokines, such as TNF-𝛼, IL-6, and CRP (Sun et al.,
2019).
Little information has been reported concerning piceatannol, a
hydroxylated analog of resveratrol. The administration of piceatan-
nol lowers blood glucose levels in db/db mice (Uchida-Maruki et al.,
2015). Unfortunately, the authors did not analyze the mechanisms
underlying the glucose-lowering effect of piceatannol. Skeletal mus-
cle can be involve in the beneficial effects because Minakawa et al.
(2012) observed that piceatannol increased the glucose uptake in L6
myotubes through promotion of GLUT4 translocation to plasma mem-
brane via AMPK activation.
4.8 Procyanidins
Procyanidins (PCs) are polyphenolic compounds that belong to the
class of flavonoids and are oligomers of monomeric flavan-3-ols (+)-
catechin and (-)-epicatechin (Gonzalez-Abuin et al., 2015) (Figure 7).
The B-type PCs are formed by monomeric units linked to each other
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F IGURE 7 Structure of procyanidins
by a single linkage (C4-C8 or C4-C6). Besides these single linkages, an
additional ether bond can be present (C2-O-C7 or C2-O-C5), which is
referred to as A-type. PCs are widespread in the plant kingdom. Well-
known PC food sources are cocoa, cinnamon, apple, grape seeds, wine,
and nuts, which possess anti-inflammatory and antioxidative effects
related with the pathophysiology of insulin resistance and type 2 dia-
betes mellitus.
Animal studies provide a great opportunity to assess the contri-
bution of physiological effects regarding PC consumption in different
models of diabetes. In studies performed on rats fed a diet rich in fruc-
tose, procyanidins had a clear hypoglycemic effect (Cremonini, Bet-
taieb, Haj, Fraga, & Oteiza, 2016). Pinent, Cedo, Montagut, Blay, and
Ardevol (2012) analyzed the effects of procyanidins based on the spe-
cific origin of each type of disruption in glucose homeostasis, and found
that the mode of administration is important for efficacy, suggesting
that PCs are more effective when administered in a single acute dose
than when mixed with food, and that antihyperglycemic effects were
more controversial in insulin resistance induced by high fat diets, com-
pared to diets rich in fructose. In a study conducted on rats fed with
a high-fat diet, Baiges, Palmfeldt, Bladé, Gregersen, and Arola (2010)
assumed that the improvement in hyperglycemia was related to the
effects of procyanidins that suppressed liver lipogenesis, which is a
major player in the progress to insulin resistance, dependent on liver
proteomics.
In a study aimed to clarify the effects of specific types of procyani-
din oligomers in different cinnamon species, the results showed that
two of the three samples of Cinnamomum cassiawere rich in procyani-
din type B and the other sample rich in procyanidin type A. Cinna-
mon extracts were given to mice with fat-rich diet and low-dose STZ
induced diabetes for 14 days. Blood glucose concentrations decreased
significantly in all cinnamon extract groups compared to the control
group. These results suggest that both procyanidinic type A and type
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B oligomers have hypoglycemic activity and can improve insulin sensi-
tivity in type 2 diabetes. (Lu et al., 2011).
In another study investigating the effects of oral administration of
PCs from apples on glucose metabolism using db/db diabetic mice,
an improvement in glucose tolerance, insulin resistance, and hep-
atic gluconeogenesis was observed, by suppressing pro-inflammatory
cytokine expression. It has been suggested that suppression of hep-
atic inflammation may be a mechanism with possible beneficial health
effects in diseases with disrupted glucose metabolism. When C. cas-
sia extract (CC-E) and Cinnamomum tamala extract (CT-E) rich in B-
and A-type procyanidin oligomerswere administered by gavage to dia-
betic db/db mice in a study conducted by Chen et al. (2012), it was
observed that both CC-E and CT-E exhibited antidiabetic effects and
that lipid accumulation in the adipose tissue and liver was inhibited
by CC-E, whereas CT-E mainly improved seric and pancreatic insulin
concentration.
A study on male mice explored the protective effects of procyani-
din A2 against glucose homeostasis disturbance and gene expression
of pancreatic and duodenal homebox 1 (Pdx1) as well as glucose trans-
porter 2 (Glut2) induced by bisphenol A (BPA). The results showed
that procyanidin A2 strongly prevents islet cells apoptosis and that
co-administration of procyanidin A2 and BPAmodified hyperglycemia.
BPA reduced Pdx1, Glut2 mRNA expression, and antioxidant levels
in pancreatic tissue, whereas procyanidin A2 prevented these effects.
These findings suggest that use of plants rich in procyanidin A2 has
preventive effects on T2D (Ahangarpour, Afshari, Mard, Khodadadi,
& Hashemitabar, 2016). Another study, using dimeric and tetrameric
PCs from black soybean seed coat extracts, focused on translocation
of glucose transporter 4 (GLUT4), hypoglycemic effects, and underly-
ingmolecularmechanisms in skeletalmuscle ofmice. Thehypoglycemic
effects of procyanidins were compared with those of (-)-epicatechin
andmajor the anthocyanin cyaniding 3-O-𝛽-glucoside (C3G)monomer.
Theobtained results showed that the trimeric and tetrameric procyani-
dins activated both insulin and AMPK signaling pathways to induce the
translocation of GLUT4 in mice skeletal muscle. It has been confirmed
that procyanidins suppressed acute hyperglycemia induced by an oral
glucose tolerance test in a dose-dependent manner. Among these ben-
eficial effects, cinnamatin A2, one of tetramers, was most effective
(Yamashita et al., 2016).
In diabetes, decreased levels of beta cell sirtuin SIRT1 could be a
key step in the onset of beta cell dysfunction, occurring via abnor-
mal elevation of ROS levels and amplification of beta cell IL1𝛽 syn-
thesis. Aragones et al. (2016) demonstrated that proanthocyanidin
(PAC) administration increased dose dependently the hepatic NAD+
content and mRNA levels of genes involved in the pathway of NAD+
biosynthesis in the livers of healthy rats. The concomitant activation
of SIRT1 by PACs was the result of increasing both the cellular NAD+
and SIRT1 concentrations. This represents an attractive strategy to
increase beta cell activity in the future. The results of these animal
studies show that the hypoglycemic effect of PCs and their bene-
fits as antidiabetic agents are mediated by various mechanisms and
by structure–activity relationship. Some mechanisms include insulin-
mimetic effects on liver and peripheral tissues, as well as on beta
cell function and/or mass. Procyanidins may also have complementary
effects in collateral aspects related to diabetes (e.g., lipid accumulation
and inflammatory profile).
Inhibition of is also an accepted strategy to prevent diabetes. PACs
bind, precipitate, and inhibit enzymes in the digestive process, being
potential bioDrugs. PAC degree of polymerization is responsible for
differential inhibitory potency. Vazquez-Flores et al. (2018) used four
semipurified fractions from Carya illinoinensis kernels rich in oligomeric
and polymeric PACs, which showed different inhibitory activity against
intestinal proteases, lipases, and amylases, as predicted by in silico
methods. The authors conclude that small oligomeric PACs could be
inhibitors of digestive enzymes due to their capacity to enter and bind
to the enzymes’ specific cavities and suggest that experimental test-
ing of this hypothesis may have a major role in understanding health-
related biological actions of PACs.
4.9 Proanthocyanidins
In this scenario, numerous in vitro and in vivo studies have been per-
formed to elucidate the antidiabetic mechanisms of proanthocyani-
dins, including reduction of carbohydrate digestion,modulation of hep-
atic glucose metabolism, protection of pancreatic 𝛽-cell function, and
impact of skeletal muscle on glucose uptake. Proanthocyanidins have
been reported to inhibit 𝛼-glycosidase, an enzyme that breaks down
starch and disaccharides to glucose (Johnson, de Mejia, Fan, & Lila,
2013; Lee, Cho, Tanaka, & Yokozawa, 2007; Schafer & Hogger, 2007),
thus reducing carbohydrate digestion and consequently, the availabil-
ity of glucose for absorption in intestine. It has been suggested that this
activity increases as the molecular weight of the polyphenol increases
(Ma, Sato, Li, Nakamura, & Hattori, 2010). Some authors have also
observed the inhibition of 𝛼-amylase, the enzyme that hydrolyzes the
1,4-glycosidic bonds in both amylose and amylopectin, but this result is
controversial (Johnson et al., 2013).
As far as the modulation of hepatic glucose metabolism is con-
cerned, proanthocyanidins increase glucose uptake and limit glucose
output. It has been reported that these compounds increase hepatic
glucokinase activity. This enzymephosphorylates glucose to glucose-6-
phosphate, thus facilitating the storage of glucose as glycogen and the
disposal of glucose by glycolysis (Zhang et al., 2007). These polyphe-
nols also decrease phosphoenolpyruvate carboxykinase, an enzyme
that catalyzes an irreversible step of gluconeogenesis (Bang &Choung,
2014). Moreover, proanthocyanidins decrease glucose-6-phosphatase
via activation of AMPK and PI3K/Akt pathways (Cordero-Herrera,
Martin, Bravo, Goya, & Ramos, 2013; Kurimoto et al., 2013).
With regard to the effects on pancreatic 𝛽-cell function, proan-
thocyanidins are considered insulin secretagogues. Proanthocyanidins
modulate pancreatic 𝛽-cell functions, such as prevention of oxidative
stress, enhancement of insulin secretion, and promotion of 𝛽-cell sur-
vival (Yang & Chan, 2017). This ability to stimulate insulin secretion
depends on several factors. One of them is the number of hydroxyl
groups on their chemical structure; those compoundswith higher num-
ber of hydroxyl groups are more effective (Chen et al., 2016). Another
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important factor is the dose. Thus, in prolonged treatments, doses in
the range of 25 mg/kg body weight are less effective than doses in the
range of 15 mg/kg body weight. Ho, Kase, Wangensteen, and Barsett
(2017) have demonstrated that proanthocyanidins stimulate glucose
uptake in humanmyotubes in a range of concentrations of (0.1–10µM).
Unfortunately, in this study the exact mechanism explaining this effect
(for instance the effect on GLUT1 and GLUT4 glucose transporters)
was not addressed.
Specially, grape seed proanthocyanidins are benefits for diabetic
complications through attenuating diabetic nephropathy (Gao et al.,
2018), preventing early functional and morphological abnormalities in
the peripheral nerves (Ding, Dai, Jiang, Zhang, & Li, 2014), ameliorating
pancreatic 𝛽-cell dysfunction and death (Hu, Shi, Chen, Zou, & Li, 2018)
and glycation-associated cardiac damage (Cheng et al., 2007), protect-
ing against early diabetic peripheral neuropathy by modulating endo-
plasmic reticulum stress (Ding, Dai, Zhang, et al., 2014), and inhibiting
oxidative stress-induced vascular impairment in pulmonary arteries in
diabetic animals (Pinna, Morazzoni, & Sala, 2017).
4.10 Tannins
Tannins are a heterogeneous groupofwater-soluble polyphenolic com-
poundsof highmolecularweight (500–3,000Daltons)with20hydroxyl
groups, present in plants, foods, and beverages. Tannins can delay
intestinal glucose absorption and the onset of insulin-dependent dia-
betes mellitus by producing an insulin-like effect on insulin-sensitive
tissues, which lowers glucose levels by regulating the antioxidant envi-
ronment of pancreatic 𝛽-cells (Serrano, Puupponen-Pimiä,Dauer, Aura,
& Saura-Calixto, 2009). Field bean, sweet potato, and amaranth leaves
exhibit effective 𝛼-amylase inhibition activity. Amaranth leaves and
sweet potatoes having the highest activity. Similarly, the tannin and
ellagic acid derivatives from Banaba (Lagerstroemia speciosa L.) leaves
have been reported to be potent inhibitors of 𝛼-amylase (Hosoyama,
Sugimoto, Suzuki, Sakane, & Kakuda, 2003). Zhang and Kashket (1998)
also identified tannins as the bioactive constituents in green and black
teas responsible for inhibition of 𝛼-amylase.
Condensed tannins present in acetonic extract of food ingredi-
ents can significantly inhibit 𝛼-glucosidase. Finger millet, field bean,
sweet potato, and drumstick leaves, which have the highest tannin
content, are most effective inhibitors of 𝛼-glucosidase. Tannins have
been reported to effectively inhibit intestinal 𝛼-glucosidase activ-
ity similar to synthetic inhibitors such as acarbose and voglibose,
which are already being used therapeutically to control noninsulin-
dependent diabetes mellitus (Matsui et al., 2007). A study of patients
with noninsulin-dependent diabetes mellitus revealed that tannic acid
and tannin-rich nonalcoholic compounds of red wine can reduce the
serum glucose levels after starch-rich meals (Gin, Rigalleau, Caubet,
Masquelier, & Aubertin, 1999).
Acacia polyphenols extracted from the bark of the black wattle tree
(Acacia meansii) are rich in unique catechin-like flavan-3-ols, such as
robinetinidol and fisetinidol. Acacia polyphenols showed the antiobe-
sity/antidiabetic effects on obese diabetic KKAy mice (Ikarashi et al.,
2011). Acacia polyphenols increased mRNA expression of adiponectin
and decreased mRNA expression of TNF-𝛼 and PPAR𝛾 in white adi-
pose tissue. Furthermore, Acacia polyphenols significantly reduced the
mRNA expression of GLUT4 in skeletal muscle (Ikarashi et al., 2011).
Tannic acid has an insulin-like glucose transport stimulatory
activity in adipocytes, whereas it exhibits “anti-insulin” activity in
preadipocytes. Thebanabaextractwithout tannic aciddidhaveglucose
transport-stimulatory or adipocyte differentiation-inhibitory activity.
It is possible that tannic acid regulates both activities through differ-
ent targets and signaling pathways. Tannic acid did not induce any
Insulin resistance-independent glucose transport, strongly supporting
that tannic acid applied the insulin-mediated pathway(s) exclusively for
glucose transport. Tannic acid stimulated phosphorylation of protein
factors in the insulin-mediated glucose transport pathway (Liu et al.,
2005).
A study on 36 diabetic Wistar rats revealed that a combination of
hydrolysable tannin from Chinese natural gallnuts and condensed tan-
nin from the bark of the black wattle tree (Acacia mearnsii) rich in gal-
lotannins and catechins decreased the glycemic levels, which delayed
carbohydrate digestion (Kato et al., 2017). The bark of Cinnamomum
zeylanicum (a species of cinnamon) rich in tannins and flavonoids inhib-
ited 𝛼-glucosidase and decreased glycemic levels on streptozotocin-
induced diabetic rats due to chronic malabsorption of carbohydrates
(Choudhury et al., 2018).
4.11 Curcumin
In animalmodels, curcumin and extracts rich in curcumin postpone dia-
betes development, protect beta-cell, decrease insulin resistance, reg-
ulate lipidmetabolism, reduce diabetic cardiomyopathy, attenuate tes-
ticular injury and oxidative stress (Jin et al., 2018; Pivari, Mingione,
Brasacchio, & Soldati, 2019; Rashid, Chowdhury, Ghosh, & Sil, 2017;
Zha et al., 2018), as well as ameliorate diabetic complications, such as
liver disorders, adipocyte dysfunction, neuropathy, nephropathy, vas-
cular diseases, and pancreatic disorders (Zhang, Fu, Gao, & Liu, 2013).
Curcumin analogs with shortened central seven-carbon chain hardly
show hypoglycemic effects but potentially helpful for alleviating dia-
betes complications, whereas curcumin analogs preserving this chain
reserve the hypoglycemic effects. For example, tetrahydrocurcumin
(Figure8) exhibited stronger antidiabetic activity than that of curcumin
in hypoglycemic effect, improving carbohydrate metabolism, amelio-
rating liver and kidney injury, and restoring antioxidant enzymes activ-
ity (Rivera-Mancia et al., 2015).
5 HUMAN STUDY AND CLINICAL TRIALS
5.1 Clinical and human data of polyphenols as
antidiabetic agents
Despite an abundance of in vitro and in vivo evidence, there are very
few clinical reports that demonstrate the effectiveness of polyphenols
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F IGURE 8 Chemical structure of curcumin and tetrahydrocurcumin
as a therapeutic agent against T2D. Here, we embark on randomized
and concurrent clinical studies to evaluate the efficiency of polyphe-
nols in management of diabetes to gain a better insight into its biologi-
cal effects in humans.
Daily supplementation of 1,500 mg curcumin can decrease fast-
ing blood glucose and weight and alleviate diabetic complications in
type 2 diabetic patients in a randomized, double-blind clinical trial
(Adibian et al., 2019; Hodaei, Adibian, Nikpayam, Hedayati, & Sohrab,
2019). A 9-month curcumin intervention prevents the prediabetes to
develop T2D via improving overall function of 𝛽-cells (Chuengsamarn,
Rattanamongkolgul, Luechapudiporn, Phisalaphong, & Jirawatnotai,
2012). Supplementation of both curcumin (1,000 mg/day) and piper-
ine (10 mg/day) for 12-week period to 118 patients with T2D resulted
in increased adiponectin and decreased leptin levels along with
decreased inflammation.
Certain clinical studies have convincingly proved the antidiabetic
effect of resveratrol; this could be resulting from improved glycemic
control and insulin resistance. The first randomized clinical trial proved
that resveratrol supplementation improves insulin sensitivity along
with reductionof oxidative stress inT2Dpatients (Brasnyoet al., 2011).
The effect of resveratrol administered at 1 g/day for a period of 45 days
wasbeneficial for T2Dpatients, as they showed improved levels of fast-
ing bloodglucose,HbA1c, insulin, and systolic pressure (Movahedet al.,
2013). Other clinical studies, however, reported contradicting results.
Thazhath et al. (2016) conducted a randomized trial and supplemented
resveratrol (500 mg) twice daily for 5 weeks to T2D patients, which
revealed no significant improvement in glycemic control (Thazhath
et al., 2016). In another placebo-controlled, double-blind, random-
ized trial, conducted in 2016, revealed that resveratrol treatment
(500 mg/day) for 6 months did not improve metabolic parameters in
T2D (Bo et al., 2016). Resveratrolmay improve glycemic control (Bhatt,
Thomas, & Nanjan, 2012) and neurovascular coupling and cognitive
performance in T2D (Wong, Raederstorff, & Howe, 2016). Resveratrol
supplementation does not improve hepatic or peripheral insulin sensi-
tivity (Timmers et al., 2016), In patientswith diet-controlled type 2 dia-
betes, 5weeks of twice-daily 500-mg resveratrol supplementation had
no effect on GLP-1 secretion, glycemic control, gastric emptying, body
weight, or energy intake (Thazhath et al., 2016).
A randomized controlled trial conducted with 60 T2D patients
administered green tea-extract powder daily for 2 months showed
reduction in HbA1c level and diastolic blood pressure, whereas
changes in body weight, systolic blood pressure, fasting blood glucose,
HOMA index, and lipid levelswere not observed (Fukino et al., 2008). In
contrast, in clinical trial of T2D subjects administeredwith 1,500mg of
green tea, no significant changes in fasting HbA1C, blood glucose, and
lipoproteins were observed (Hsu et al., 2011).
Berberine, an isoquinolien alkaloid of barberry, regulates carbohy-
drate and fat metabolism in vitro and in vivo. A meta-analysis of 14
clinical studies reported the effects of berberine to be like those of
commercially available drugs such as glipizide, metformin, and rosigli-
tazone (Dong,Wang, Zhao, & Lu, 2012). Supplementation of berberine
increased plasma antioxidant activity and lowered blood glucose and
altered lipid profile in T2Dpatients. Yin, Xing, and Ye (2008) conducted
a study in Chinese population with 36 newly diagnosed T2D with
berberine supplementation (1.5 g/day) for a 3-month trial and proved
its efficiency comparable to metformin. In the same study, berberine
supplementation to 48T2Dpatients at a dosage of 500mg, thrice daily,
for 3months resulted in decrease in blood glucose levelswithin aweek.
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Clinical trials have investigated the impact of supplementation of
quercetin, one of the most abundant flavanoids, on T2D subjects.
Single oral dose (400mg) of quercetin effectively suppressedpostpran-
dial blood glucose levels in patients with T2D loaded with maltose,
which may be attributed to 𝛼-glucosidase inhibition (Hussain, Ahmed,
Mahwi, & Aziz, 2012). Also, 100 mg of quercetin capsules each day for
49 patients for 10 weeks reduced cardiometabolic risks in male smok-
ers and improved blood glucose, lipid profiles, and blood pressure in a
clinical setup (Lee et al., 2011), whereas 47 T2D patients on diet sup-
plemented with either quercetin (250 mg/d) or identical placebo (cel-
lulose) capsules administered orally for 8 weeks showed no significant
hypoglycemic and/or hypolipidemic effects (Zohreh, Seyedeh, Moham-
mad, & Abbas, 2014).
Anthocyanins exhibit antidiabetic property by reducing the levels
of blood glucose and HbA1c, increasing the secretion of insulin, and
improving insulin resistance. Liu et al. (2014) demonstrated that antho-
cyanins improved the endothelium-dependent vasodilation in diabetic
individuals through the induction of adiponectin. Experimental stud-
ies have shown that cinnamon could be attributed to its beneficial
effects on hyperlipidemia and glucose utilization. A clinical study with
total of 60 T2D patients demonstrated that cinnamon supplementa-
tion (1–6 g/day) reduced the levels of blood glucose, serum triglyceride,
and both Low density lipoprotein and total cholesterol in T2D patients
(Khan, Safdar, Khan, Khattak, & Anderson, 2003).
Capsaicin is a polyphenol found in chili peppers reported for ther-
apeutic uses in diseases such as diabetes, cardiovascular diseases, and
cancer. In a clinical trial, supplementation of 5 g of Capsicum frutescens
T2Dpatients resulted in a reduction in plasma glucose levels andmain-
tenance of insulin levels (Chaiyasit et al., 2019).
5.2 Clinical and human data of extracts or diet rich
in polyphenols as antidiabetic agents
A randomized controlled trial found that a diet naturally rich in
polyphenols improves glucose metabolism in individuals at high risk
of diabetes (Bozzetto et al., 2015). A 4-week, double blind, random-
ized, placebo controlled trial involving 32 T2D patients showed that
flavonoid-rich grape seed extracts significantly improved the biomark-
ers of inflammation, glycemia, and oxidative stress in the events of
obese T2D subjects at high risk of cardiovascular (Kar, Laight, Rooprai,
Shaw, & Cummings, 2009). A double-masked, randomized controlled
trial found that the daily intake of flavanol-containing cocoa might
improve the vascular function of medicated T2D patients (Balzer
et al., 2008). A randomized, double-blind, placebo-controlled trial with
48 T2D patients revealed that a 12-week daily supplementation of
Pycnogenol R© (125 mg), a French maritime pine bark extract rich
in procyanidins and bioflavonoids, could increase diabetes control,
reduce cardiovascular disease risk factors, and lower antihypertensive
medicine use vs controls (Zibadi, Rohdewald, Park, & Watson, 2008).
In a double-blind, 8-week randomized controlled study involving in 80
T2D patients, Brazilian green propolis (226.8 mg/day) rich in polyphe-
nols and flavonoids was found to prevent T2D patients from worsen-
ing developments in blood uric acid and estimated glomerular filtra-
tion rate (Fukuda et al., 2015). A randomized, double-blind, placebo-
controlled trial (34 subjects) showed that the supplementation of aca-
cia polyphenol (250 mg/day) might improve glucose homeostasis in
nondiabetic subjects with impaired glucose tolerance (Ogawa, Mat-
sumae, Kataoka, Yazaki, & Yamaguchi, 2013).
Coffee polyphenols can improve peripheral endothelial function fol-
lowing glucose loading in healthy male adults (Ochiai et al., 2014). Cof-
feeswith different contents of chlorogenic acids did not showdifferent
degrees of influence on glucose or insulin responses in healthy humans
(Rakvaag&Dragsted, 2016). Redwine polyphenolswere found to have
a beneficial effect on insulin resistance and lipoprotein plasma concen-
trations in a randomized clinical trial involving 67menwith high cardio-
vascular risk (Chiva-Blanch et al., 2013). Awhortleberry extracts rich in
anthocyanins significantly lowered the levels of fasting blood glucose,
2-hr postprandial glucose, and HbA1c in a randomized, double-blind,
placebo-controlled clinical trial, consisting of 37 T2D patients (Kian-
bakht, Abasi, & Dabaghian, 2013).
Supplements of high-polyphenol chocolate could protect against
endothelial dysfunction and oxidative stress in T2D during acute
transient hyperglycemia, as induced by a 75-g oral glucose chal-
lenge in a double-blinded randomized controlled crossover study (Mel-
lor, Madden, Smith, Kilpatrick, & Atkin, 2013). Daily consumption of
polyphenol-rich extra-virgin olive oil might improve metabolic control
and the profile of circulating inflammatory adipokines in overweight
T2D patients (Santangelo et al., 2016). The powdered dried leaves
of Eugenia punicifolia (Kunth) DC. (Myrtaceae), rich in flavonol glyco-
sides, are effective as an adjuvant to the treatment of T2D patients.
In a pilot noncontrolled study, a 3-month treatment with powdered
dried leaves of E. punicifolia was found to significantly reduce glycosy-
lated hemoglobin and basal insulin levels (Sales et al., 2014). The aque-
ous extract (0.15% infusions) of Bauhinia forficata (L) subsp. pruinosa
(Fabaceae), rich in rutin, could significantly reduce HbA1c concentra-
tion in diabetic and prediabetic volunteers (n = 15) (Toloza-Zambrano,
Avello, & Fernandez, 2015). However, the onion extract did not show a
hypoglycemic effect on healthy volunteers in an oral glucose tolerance
test.
In summary, polyphenols from coffee, guava tea, whortleberry,
olive oil, propolis, chocolate, red wine, grape seed, and cocoa have
shown antidiabetic effects in T2D patients by increasing glucose
metabolism, improving vascular function, and reducing insulin resis-
tance andHbA1c.
6 DIETARY POLYPHENOLS AND THE GUT
MICROBIOME FOR DIABETES
The gut microbiota composition has been associated with several
trademarks of chronic diseases (e.g., obesity, type 2 diabetes, cardio-
vascular diseases, and nonalcoholic steatohepatitis). Certain types of
bacteria are linked with some diseases, whereas others are mainly
important for our health (Everard & Cani, 2013). In recent years,
gut microbiota has gained growing attention as a novel factor in the
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management of diabetes. Several well-known researches indicated
that the gut microbiota differed completely between type 2 diabetic
patients and healthy people. Larsen et al. (2010), for instance, carried
out studies on the differences between the composition of the intesti-
nalmicrobiota in T2Dpatients and nondiabetic persons. They reported
that the proportions of the phylum Firmicutes and the class Clostridia
were significantly reduced,whereasBetaproteobacteria, positively cor-
related with plasma glucose, was highly enriched in the feces of T2D
patients compared with nondiabetic persons. Interestingly, food also
affected the diversity of human gut microbiota. In accordance with the
results, animal and clinical studies showed that dietary polyphenols
and polyphenol-rich foods reduced the risk of T2D and/or its compli-
cations (Nie, Chen, Hu, Fan, & Nie, 2019). In addition, polyphenols and
theirmicrobial metabolites can effectivelymodulate the balance of gut
microbiota, improving glucose metabolism (Cardona, Andrés-Lacueva,
Tulipani, Tinahones, &Queipo-Ortuño, 2013).
Limited researches have examined the effect of dietary polyphe-
nols on gut microbiota in diabetes. More recently, Lin et al. (2019) car-
ried out studies on Green Macroalgae Enteromorpha prolifera (EPW)
polyphenols in the modulation of intestinal microflora profiles in type
2 diabetic mice. They reported that EPW extract treatment signifi-
cantly increased the relative abundance of Akkermansia and decreased
the proportion of Alistipes and Turicibacter. Similarly, (Yan et al., 2019)
investigated the antidiabetic activity of extract of green macroal-
gae EPW and its flavonoid-rich fraction less than 3 kDa (EPW3) in
type 2 diabetic mice. They observed that EPW and EPW3 flavonoids
significantly changed the gut microbiota flora with an increased pro-
portion of Bacteroidetes and a reduced amount of the phylum Firmi-
cutes. Furthermore, it also increased the abundancesof Lachnospiraceae
NK4A136 group and Alisties, affecting the release of intestinal hor-
mones for regulating insulin release. The antidiabetic activity of brown
seaweed Lessonia nigrescens ethanolic extract (LNE), including pheno-
lics and flavonoids, was investigated in type 2 diabetic mice fed with
a high-sucrose/high-fat diet by (Zhao et al., 2018). They showed that
the intake of LNE increased the growth of Barnesiella,Helicobacter, and
Turicibacter, whichwere able to stimulate the host’s antidiabetic effect,
accompanied with the modification in the gene and protein expres-
sion of hepatic phosphatidylinositol 3-kinase and c-Jun N-terminal
kinase.
It is worth noting that the difference apart from conventional treat-
ments, a novel area of research for developing new strategies to tackle
T2D using gut microbes is recognized. Akkermansia (reported to have
effects on obesity, T2D, and gut inflammation) has recently been pro-
posedas anewbiomarkerof intestinal health, indicating that themodu-
lationof theAkkermansiamayhavebeneficial effects onType2diabetes
(Blandino, Inturri, Lazzara, Di Rosa, & Malaguarnera, 2016; Delzenne,
Cani, Everard, Neyrinck, &Bindels, 2015).Moreover, polyphenolswere
also found to positively regulate Akkermansia (Everard & Cani, 2013).
For example, grape (Roopchand et al., 2015) and cranberry (Anhê et al.,
2015) extracts rich in polyphenols were found to markedly increase
the abundance of Akkermansia. Based on these findings, Akkerman-
sia thwarts the deleterious increase in gluconeogenesis in diabetes,
preventing the increase in glucose-6-phosphatase mRNA expression
(Everard, Belzer, et al., 2013). Similarly, Bifidobacteria also potentially
play protective role in preventing T2D. Some studies showed that
polyphenols also promoted the growth of Bifidobacteria (Bialonska
et al., 2010), for instance, it was also observed that the pomegranate
extract enhanced the total growth of Bifidobacterium spp. and Lacto-
bacillus spp. The authors suggested that pomegranate oligomers com-
posed of gallic acid, ellagic acid, and glucose units may account for
the enhanced growth of specific bacteria. Likewise, Vendrame et al.
(2011) observed a significant increase in the amount of Bifidobac-
terium after the consumption of a wild blueberry drink, suggesting an
important role of the polyphenol present in wild blueberries on the
intestinal microbiota composition modulation. This association may be
related to Bifidobacteria-restored gut barrier function and reduce gut
epitheliumpermeability thus preventing the penetration of pathogenic
organisms and inflammatory substances such as lipopolysaccharides.
Hence, Bifidobacteria potentially plays a protective role in T2D (Klinder
et al., 2016). In addition to Akkermansia and Bifidobacteria, Faecalibac-
teriummight be beneficial in the treatment of diabetes (Blandino et al.,
2016). For example, redwine polyphenols significantly changed the gut
microbiota by increasing the number of fecal Bifidobacteria and Lacto-
bacillus (intestinal barrier protectors) and butyrate-producing bacte-
ria (Faecalibacterium prausnitzii) (Moreno-Indias et al., 2016). It could
be related to the role of the short-chain fatty acids such as butyrate
formed by this gut microbiota in the regulation of the levels of gut
hormones such as glucose-dependent insulinotropic polypeptide and
glucagon-like peptide 1, which have important effects on carbohydrate
metabolism (Moreno-Indias et al., 2016). Another study showed that
the fecal samples of 174 healthy controls and 171 diabetic patients
showed that diseased samples had lesser abundance of F. prausnitzii,
butyrate-producing bacteria (Qin et al., 2012). In addition, the ratios of
Bacteroidetes to Firmicutes significantly and positively correlated with
reduced glucose tolerance (Larsen et al., 2010). Zhao, Chen, Yin, and Li
(2017) showed that L. nigrescens ethanolic extract, rich in phenolics and
flavonoids, hadbetter glycemic control on type2diabeticmice, increas-
ing the abundanceofBacteroidetesand reducedFirmicutespopulation in
intestine.
Polyphenols and its degraded metabolites can also help amelio-
rate T2D. These components transformed by certain gut microbiota
into secondary metabolites generally have greater absorption and
bioactivity than their precursors (Nie et al., 2019). The microbial-
derived flavonoid metabolites 3,4-dihydroxyphenylacetic acid and
3-hydroxyphenylpropionic acid may have antidiabetic potential by
promoting survival and function of pancreatic 𝛽-cells (Fernández-
Millán et al., 2014). Moreover, microbial metabolites of polyphenols
might regulate the production of bile acids, which affect the host
metabolism.
In short, studies have shown that there is a strong interaction
between polyphenols and gut microbiota, which have the ability to
protect against diabetes (Figure 9): first, polyphenols change the
gut microbiota and promote growth of beneficial bacteria such as
Akkermansia, Bifidobacteria, Faecalibacterium prausnitzii, and so on; sec-
ond, not only polyphenols but also their microbial metabolites have
greater bioactivity against diabetes; third, further studies are needed
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F IGURE 9 Effect of polyphenols and gut microbiota on diabetes
to clarify the role of polyphenols/their microbial metabolites in gut
microbiota.
7 DIABETIC STATUS INFLUENCES THE
BIOAVAILABILITY OF DIETARY
POLYPHENOLS
The hyperglycemic status could affect the bioavailability of small
molecule drugs by regulating absorption, distribution, biotransforma-
tion, and excretion. The bioavailability between drugs and dietary
polyphenols is different in dose per day, complexity of the com-
ponents, and interaction with food. Dietary polyphenols are poorly
absorbed, highly metabolized, or rapidly eliminated. Only about 5–
10% of polyphenols can be absorbed, and over 90% of polyphenols
digested pass to the colon. In contrast, clinical drugs are typically suf-
ficiently absorbed and transported to their target tissues. The hyper-
glycemic status significantly affects the carbohydrate, protein, and
lipid metabolism. The systems that regulate these biochemical path-
ways are also in many cases involved in phytochemicals biotransfor-
mation. Thus, the hyperglycemia obviously influences the bioavailabil-
ity of dietary polyphenols. For example, compared with healthy ani-
mals, a significant increase ofCmax andArea under curve ofmangiferin,
baicalin, wogonoside, and oroxyloside in diabetic animals was found
(Xiao & Högger, 2015; Zhang et al., 2018). The bioavailability of phlo-
rizin was significantly improved in type 2 diabetic rats (Wang et al.,
2019). Absorption of cynaroside, quercetin, luteolin, isorhamnetin,
rutin, and formononetin in the diabetic rats was significantly higher
than those in the normal rat (Wei, Chen, Liu, & Wei, 2017). However,
Cmax values for catechin, epicatechin, quercetin, and resveratrol conju-
gated metabolites were diminished in Zucker diabetic fatty rat (Chen
et al., 2017). The bioavailability of methylated flavan-3-ol, resvera-
trol, and quercetin metabolite was significantly lower in Zucker dia-
betic fatty rat (Chen et al., 2017). Moreover, very little progress for
hyperglycemia-mediated changes in bioavailability of bioactive phyto-
chemicals has been archived. An understanding of how hyperglycemia
altering the bioavailability of dietary polyphenols will lead to improve
the benefits and clinical outcomes of these phytochemicals.
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F IGURE 10 Antidiabetic effects of dietary polyphenols
8 PERSPECTIVES
T2D is one of the most serious public health problems in the world.
Nonpharmacological (reasonable diet and exercise) or pharmacologi-
cal approaches (drugs or insulin) are known to control T2D. However,
the pharmacotherapy for T2D is a considerable cost for patients and
has serious side effects. The use of plants appears as an attractive
alternative to the classical antidiabetic treatment. They contain com-
plex substanceswithmany natural bioactive principles thatwould have
fewer side effects. Determining how these different plant-specialized
metabolites and other dietary constituents interact in the human body
is important. Are these effects additive, synergistic, or antagonistic
with respect to antidiabetic treatment? Novel antidiabetic treatments
must ensure products of consistent quality in enough quantities to
improve the health of millions.
Dietary polyphenols are the most abundant phytochemicals in
human diet and have attracted great interests since the 1990s due
to growing evidence of their beneficial effects for humans. In animal
level, dietary polyphenols prevent and manage T2D and ameliorates
diabetic complications (Figure 10). The structure–activity relationship
of polyphenols as antidiabetic agents is still not clear. Moreover,
individual flavonoid or isoflavone has no therapeutic effect on diabetic
patients, although the clinical data are very limited. Resveratrol,
curcumin, and anthocyanins showed antidiabetic activity in humans.
How T2D influences the bioavailability and bioactivity of dietary
polyphenols is not well understood. An understanding of how diabetes
alters the bioavailability and bioactivity of dietary polyphenols will
lead to an improvement in their benefits and clinical outcomes.
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